ADVFN - Advanced Financial Network.
HOME» NASDAQ » C » CYTK Stock Price » CYTK Stock News

Cytokinetics Incorporated Share News

 Cytokinetics, Incorporated (mm) Stock Price
CYTK Stock Price
 Cytokinetics, Incorporated (mm) Stock Chart
CYTK Stock Chart
 Cytokinetics, Incorporated (mm) Stock News
CYTK Stock News
 Cytokinetics, Incorporated (mm) Company Information
CYTK Company Information
 Cytokinetics, Incorporated (mm) Stock Trades
CYTK Stock Trades

Registration Effectiveness Orders Issued By The SEC

The following table includes registration statements and post-effective amendments that were declared effective by the Securities and Exchange Commission on the most recently completed business day. The Securities Act of 1933 requires companies offering securities to file a registration statement with the SEC that discloses material facts for investors. The SEC staff reviews registration statements and declares them "effective" if companies satisfy the disclosure rules. REGISTRATIONS EFFECTIVE AS OF December 8, 2011 IPO: Memorial Production Partners LP (MEMP) File Number: 333-175090 Date of Original Registration: 6/23/11 Form Type: S-1 Securities Registered: $287,500,000 Common units representing limited partner interests Selling Holder: No Rose Rock Midstream, L.P. (RRMS) File Number: 333-176260 Date of Original Registration: 8/12/11 Form Type: S-1 Securities Registered: $181,125,000 Common units representing limited partner interests Selling Holder: No STOCK: ADVENTO, INC. File Number: 333-174607 Date of Original Registration: 5/31/11 Form Type: S-1 Securities Registered: 2,000,000 SHARES OF COMMON STOCK Selling Holder: No Advaxis, Inc. (ADXS) File Number: 333-178172 Date of Original Registration: 11/23/11 Form Type: S-1 Securities Registered: 24,130,782 Shares of Common Stock Selling Holder: Yes Campus Crest Communities, Inc. (CCG) File Number: 333-177648 Date of Original Registration: 11/1/11 Form Type: S-3 Securities Registered: 285,593 Shares of Common Stock Selling Holder: Yes GENERAL ELECTRIC CO (GE) File Number: 333-177803 Date of Original Registration: 11/8/11 Form Type: S-3 Securities Registered: 75,000,000 shares of Common Stock, $0.06 par value per share Selling Holder: No TIGER JIUJIANG MINING, INC. File Number: 333-166823 Date of Original Registration: 5/14/10 Form Type: S-1 Securities Registered: 1,000,000 minimum - 2,000,000 maximum shares offered by Tiger Jiujiang Mining, Inc. at a price of $0.05 per share; 1,500,000 shares offered by selling shareholders at a price of $0.05 per share Selling Holder: Yes S-4s and F-4s: Whitestone REIT File Number: 333-178098 Date of Original Registration: 11/22/11 Form Type: S-4 Securities Registered: Offer To Exchange up to 1,321,431 Class B common shares; Up to 867,789 Class A common shares; Up to 453,642 Units of Limited Partnership Selling Holder: No MIXED SECURITIES: CYTOKINETICS INC (CYTK) File Number: 333-178189 Date of Original Registration: 11/25/11 Form Type: S-3 Securities Registered: $100,000,000 COMMON STOCK, PREFERRED STOCK, WARRANTS Selling Holder: No Campus Crest Communities, Inc. (CCG) File Number: 333-177646 Date of Original Registration: 11/1/11 Form Type: S-3 Securities Registered: $750,000,000 Common Stock, Preferred Stock, Debt Securities, Depositary Shares, Warrants Selling Holder: No GENERAL ELECTRIC CO (GE) File Number: 333-177804 Date of Original Registration: 11/8/11 Form Type: S-3 Securities Registered: $20,000,000,000 Senior Debt Securities, Subordinated Debt Securities, Preferred Stock, par value $1.00 per share, Common Stock, par value $0.06 per share, Warrants, Delayed Delivery Contracts, Guarantees Selling Holder: No

Stock News for Cytokinetics Incorporated (CYTK)
DateTimeHeadline
12/02/201616:00:00Cytokinetics Announces Presentations at the International Symposium...
12/01/201607:36:24Current Report Filing (8-k)
12/01/201607:30:00Cytokinetics Announces Start of GALACTIC-HF, a Phase 3 Clinical...
12/01/201606:06:20Current Report Filing (8-k)
11/30/201618:31:00The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv...
11/30/201618:30:00The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv...
11/23/201616:32:49Current Report Filing (8-k)
11/22/201616:00:00Cytokinetics to Participate in Upcoming Investor Conferences
11/14/201616:00:00Cytokinetics Announces Presentation of Additional Results From...
11/07/201616:00:00Cytokinetics Announces New Results From COSMIC-HF to be Presented...
11/07/201607:30:00Cytokinetics Announces Publication Relating to Novel Smooth...
11/03/201616:12:36Quarterly Report (10-q)
10/27/201616:09:03Current Report Filing (8-k)
10/27/201616:00:00Cytokinetics, Inc. Reports Third Quarter 2016 Financial Results
10/18/201607:37:17Current Report Filing (8-k)
10/18/201607:30:00Cytokinetics Announces First Patient Enrolled in VIGOR-ALS, an...
10/13/201616:00:00Cytokinetics to Announce Third Quarter Results on October 27...
09/29/201607:37:15Current Report Filing (8-k)
09/29/201607:30:00Cytokinetics Announces Early Termination of Hart-Scott-Rodino...
09/19/201607:48:01Current Report Filing (8-k)

Cytokinetics Incorporated and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US